Introduction
============

With the increase in the average life expectancy of the population worldwide, cognitive frailty is emerging as one of the most important issues of human health, with a rising percentage of the population affected by cognitive decline and dementia. However, it remains impossible to delineate the precise moment at which the brain begins to age ([@B24]).

Alzheimer's Disease (AD) is the most prevalent dementia and its progression is influenced by both genetic and environmental factors ([@B29]; [@B3]; [@B32]). These gene--environment interactions may influence and trigger pathogenic pathways that determine the severity and progression of several degenerative diseases ([@B47]; [@B6]; [@B49]; [@B27]). In addition, a growing body of evidence demonstrated that the effects of environmental factors are mainly orchestrated by epigenetic mechanisms. In AD, only a small percentage of the cases (\<5%) are consistent with inheritance. Even in the familial forms of AD, penetrance is not complete and is also highly variable between individuals with the same genetic background ([@B47], [@B46]). Consequently, the effect of environmental factors is of remarkable importance. In this respect, epigenetic changes, or other forms of gene-environment interaction, could be involved in determining the onset of AD and also aging, which is the most important risk factor for development of the pathology ([@B42]; [@B65]).

In particular, lines of evidence indicate that the methylation and hydroxymethylation state of the DNA plays an important role in controlling gene expression, and also learning and memory, including memory formation and maintenance of learning and memory decline during aging ([@B40]; [@B50]; [@B41]; [@B18]; [@B48]; [@B53]).

Similarly, epigenetic mechanisms, i.e., alterations of histone proteins and DNA, are essential for hippocampal synaptic plasticity and cognitive function disease ([@B42]). Additionally, recent works ([@B34]; [@B23]; [@B26]) demonstrate that chromatin regulation, and in particular histone acetylation, could be important for modulating the cognitive outcome of several neurodegenerative disorders. Moreover, exposure to an EE has been shown to have a protective effect in mouse models by slowing disease progression and reducing AD-like cognitive impairment ([@B4]).

Although the mechanisms by which EE preserves cognition remain unknown, our work team recently demonstrated that EE is an experimental strategy to alleviate cognitive decline and neuroprotection in Senescence Accelerated Mice P8 (SAMP8) ([@B27]). Moreover, changes in modulators of epigenetic machinery, such as LSD1 or CoREST, were found changed after EE in this strain and were accompanied by cognitive feature improvements ([@B27]). These results correlated with the activation of endogenous neuroprotective pathways, thus implicating these in the beneficial effects of EE on cognition.

Many studies have demonstrated that EE changes promoter DNA methylation states while changing the expression of DNA MethylTransferases (DNMTs) ([@B14]; [@B45]; [@B43]; [@B5]). Therefore, gene-environment interactions, mediated at the epigenetic level, may be an intermediary step in providing an appropriate organism response to changes in the environment ([@B35]).

There is evidence that EE attenuated Oxidative Stress (OS) through elevated Nrf2 levels in hippocampi ([@B64]). In addition, EE elicits anti-inflammatory effects through interaction with several immune signaling pathways, including Interleukin 6 (IL-6). Diminution in the proinflammatory process after EE might be due by changes in NF-κB translocation to the nucleus, reducing chemokines ([@B16]; [@B37]; [@B70]).

The goal of the present work was to delve deep into the epigenetic mechanisms influenced by EE that rendered the previously described beneficial effects by preventing cognitive impairment and neuronal dysfunction. We focus on antioxidant and inflammaging processes modulated by EE exposure in SAMP8.

Materials and Methods {#s1}
=====================

Animals and Enriched Environmental Experimental Design
------------------------------------------------------

Male SAMP8 mice (*n* = 20) were used with free access to food and water, under standard temperature conditions (22 ± 2°C) and 12-h:12-h light-dark cycles (300 lux/0 lux).

The animals were maintained until day 21 with their mothers, and afterward were separated into cages at up to 3 months-of-age. Ten SAMP8 were employed for the Environmental Enrichment (EE) group (SAMP8 EE), and 10 were maintained under standard conditions as Control mice (SAMP8 Ct).

In the present study, we utilized the novel objects paradigm. Therefore, plastic tubes (20 cm long and 2.5 cm in diameter) were placed in EE cardboard-house cages, in addition to plastic dolls or toys, which were added, extracted, or changed each week.

Mice were treated according to European Community Council Directive 86/609/EEC and the procedures established by the Department d'Agricultura, Ramaderia i Pesca of the Generalitat de Catalunya, Spain. Every effort was made to minimize animal suffering and to reduce the number of animals.

Behavioral and Cognitive Experiments
------------------------------------

### Novel Object Recognition Test (NORT)

The protocol employed was a modification of [@B21] and [@B22]. In brief, mice were placed in a 90°-, two-arm, 25-cm-long, 20-cm-high, 5-cm-wide black maze. The walls could be removed for easy cleaning. Light intensity in mid-field was 30 lux. The objects to be discriminated were made of plastic and were chosen not to frighten the mice, and objects with parts that could be bitten were avoided. Before performing the test, the mice were individually habituated to the apparatus for 10 min during 3 days. On day 4, the animals were submitted to a 10-min acquisition trial (first trial), during which they were placed in the maze in the presence of two identical, novel objects (A+A or B+B) at the end of each arm. A 10-min retention trial (second trial) was carried out 2 h later. During this second trial, objects A and B were placed in the maze, and the behavior of the mice was recorded with a camera. Time that mice explored the New object (TN) and Time that mice explored the Old object (TO) were measured. A Discrimination Index (DI) was defined as (TN-TO)/(TN+TO). In order to avoid object preference biases, objects A and B were counterbalanced so that one half of the animals in each experimental group were first exposed to object A and then to object B, whereas the other half first saw object B and then object A. The maze and the objects were cleaned with 96° ethanol after each test in order to eliminate olfactory cues.

### Morris Water Maze Test

An open circular pool (100 cm in diameter, 50 cm in height) was filled halfway with water ([@B54]) and the temperature was maintained at 22°C ± 1. Two principal perpendicular axes were defined; thus, the water surface was divided into four quadrants (NE, SE, SW, and NW) and five starting points were set (NE, E, SE, S, and SW). Four visual clues were placed on the walls of the tank (N, E, S, and W). Non-toxic, white latex paint was added to make the water opaque, and a white escape platform was submerged 1 cm below the water level (approximately in the middle of one of the quadrants).

The animals' swimming paths were recorded by a video camera mounted above the center of the pool, and data were analyzed with SMART version 3.0 software. The learning phase consisted of 6 days of trials for each mouse. The animals were submitted to five trials each day starting from the positions set (in random order) and without a resting phase between each trial and the subsequent one. At each trial, the mouse was placed gently into the water, facing the wall of the pool, and allowed to swim for 60 s. If not able to locate the platform in this period of time, the mouse was guided to the platform by the investigator. Animals were left on the platform each time for 30 s in order to allow for spatial orientation. A memory test was performed at the end of the learning days, in which the platform was removed and the time spent and the distance swum by each mouse in each quadrant was measured.

Immunodetection Experiments
---------------------------

### Brain Processing and Subcellular Fractionation

After the behavioral test, the animals were killed by cervical dislocation. Afterward, the brains were immediately removed and the hippocampi were then isolated, frozen on powdered dry ice, and maintained at -80°C until protein extraction.

For subcellular fractionation, 150 μL of buffer A (10 mM HEPES pH 7.9, 10 mM KCl, 0.1 mM EDTA pH 8, 0.1 mM EGTA pH 8, 1 mM DTT, 1 mM PMSF, protease inhibitors) were added to each sample and incubated on ice for 15 min. After this time, the samples were homogenized with a tissue homogenizer, 12.5 μL Igepal 1% were added, and the Eppendorf was vortexed for 15 s. Following 30 s of full-speed centrifugation at 4°C, supernatants were collected (cytoplasmic fraction); 80 μL of buffer C (20 mM HEPES pH 7.9, 0,4M NaCl, 1 mM EDTA pH 8, 0.1 mM EGTA pH 8, 20% Glycerol 1 mM DTT, 1 mM PMSF, protease inhibitors) was added to each pellet and incubated under agitation at 4°C for 15 min. Subsequently, samples were centrifuged for 10 min at full speed at 4°C. Supernatants were collected (nuclear fraction) and 40 μL of buffer A+HCl (buffer A with 0.2 N HCl) was added to the pellet. After a 30-min incubation on ice, samples were centrifuged, again at full speed, at 4°C for 10 min and the supernatants were collected (the histone fraction).

### Western Blotting

For the Western blot (wb) experiment, aliquots of homogenized hippocampus, 15 μg protein for nuclear and cytoplasmic fractions, and 5 μg for the histone fraction were used. The protein samples were separated by SDS--PAGE (8--18%) and transferred onto PVDF membranes (Millipore). The membranes were blocked in 5% non-fat milk in TBS containing 0.1% Tween 20 (TBS-T) for 1 h at room temperature, followed by an overnight incubation at 4°C with the primary antibodies listed in **Table [1](#T1){ref-type="table"}**. Membranes were then washed and incubated with secondary antibodies for 1 h at room temperature. Immunoreactive protein was viewed with a chemiluminescence-based detection kit, following the manufacturer's protocol (ECL Kit; Millipore) and digital images were acquired using a ChemiDoc XRS+ System (BioRad). Semi-quantitative analyses were carried out utilizing Image Lab software (BioRad) and results were expressed in Arbitrary Units (AU). Protein loading was routinely monitored by phenol red staining of the membrane or by immunodetection of GADPH.

###### 

Antibodies used in Western blot studies.

  Antibody                           Host     Source/Catalog                WB dilution
  ---------------------------------- -------- ----------------------------- -------------
  p65                                Rabbit   Cell signaling/D14E12         1:1000
  NRF2                               Rabbit   Cell signaling/DlZ9C          1:1000
  Acetyl Histone H3                  Rabbit   Millipore/06-599              1:1000
  Acetyl Histone H4                  Sheep    R&D systems/AF5215            1:1000
  GAPDH                              Mouse    Millipore/MAB374              1:2000
  Histone H3                         Rabbit   Santa Cruz Biotech/sc-10809   1:500
  Histone H4                         Mouse    Cell signaling/L64Cl          1:1000
  TBP                                Mouse    Abcam/51841                   1:1000
  Donkey-anti-goat HRP conjugated             Santa Cruz Biotech/ sc-2020   1:3000
  Goat-anti-mouse HRP conjugated              Biorad/\# 170-5047            1:2000
  Rabbit-anti-sheep HRP conjugated            Abcam/ab97130                 1:2000
  Goat-anti-rabbit HRP conjugated             Cell signaling/tt 7074        1:2000
                                                                            

### Global DNA Methylation and Hydroxymethylation Quantification

For global DNA, methylation and hydroxymethylation was performed according to the manufacturer's instructions, first using the FitAmpTM Blood and Cultured Cell DNA Extraction Kit, which is designed for rapid isolation of pure genomic DNA from a small amount of blood or mammalian cells. The second part was performed employing the Methylflash Methylated DNA Quantification Kit (Epigentek, Farmingdale, NY, USA) and the Methylflash Hydroxymethylated DNA Quantification Kit. Briefly, methylated DNA and hydroxymethymethylated DNA were detected using capture and detection antibodies to 5-mC and 5-hmC and then quantified colorimetrically by reading absorbance at 450 nm using the Microplate Photometer. The absolute amount of methylated or hydroxymethylated DNA (proportional to the Optical Density \[OD\] intensity) was measured and was quantified using a standard curve plotting the OD values vs. five serial dilutions of control methylated DNA (0.5--10 ng).

### RNA Extraction and Gene Expression Determination

Total RNA isolation was carried out by means of Trizol reagent following the manufacturer's instructions. RNA content in the samples was measured at 260 nm, and sample purity was determined by the A260/280 ratio in a NanoDrop^TM^ ND-1000 (Thermo Scientific). Samples were also tested in an Agilent 2100B Bioanalyzer (Agilent Technologies) to determine the RNA integrity number. Reverse Transcription-Polymerase Chain Reaction (RT-PCR) was performed as follows: 2 μg of messenger RNA (mRNA) was reverse-transcribed using the High Capacity complementary DNA (cDNA) Reverse Transcription Kit (Applied Biosystems). Real-time quantitative PCR (qPCR) was employed to quantify the mRNA expression of a set of chromatin- modifying enzyme genes, including *Dnmt1. Dnmt3a. Dnmt3b*, methylcytosine dioxygenase TET1 (*Tet1*), methylcytosine dioxygenase TET2 (*Tet2*), Sirtuin 1 (*Sirt1*), Sirtuin 2 (*Sirt2*), Sirtuin 6 (*Sirt6*), Histone deacetylase 1 (*Hdac1*), Histone deacetylase 2 (*Hdac2*), OS genes Heme oxygenase (decycling) 1 (*Hmox1*), Aldehyde oxidase 1 (*Aox1*), Aldehyde dehydrogenase 2 (*Aldh2*), Cyclooxygenase 2 (*Cox2*), inflammatory genes Interleukin 6 (*IL-6*), C-X-C motif chemokine 10 (*Cxcl10*), and Tumor necrosis factor alpha (*Tnf-α*). Normalization of expression levels was performed with actin for SYBER Green and TATA-binding protein (*Tbp*) for TaqMan. The primers were those listed in **Table [2](#T2){ref-type="table"}**.

###### 

Primers and probes used in qPCR studies.

  Target               Product size (bp)       Forward primer (5′-3′)     Reverse primer (5′-3′)
  -------------------- ----------------------- -------------------------- --------------------------
  SYBR Green primers                                                      
  Dnmt1                85                      ACCTGGAGAGCAGAAATGGC       TGAAAGGGTGTCACTGTCCG
  Dnmt3b               142                     TGCCAGACCTTGGAAACCTC       GCTGGCACCCTCTTCTTCAT
  Tet1                 188                     CTGCCAACTACCCCAAACTCA      TCGGGGTTTTGTCTTCCGTT
  Tet2                 113                     CCATCATGTTGTGGGACGGA       ATTCTGAGAACAGCGACGGT
  Hdac1                150                     TCACCGAATCCGCATGACTC       TCTGGGCGAATAGAACGCAG
  Hdac2                280                     CTATCCCGCTCTGTGCCCT        GAGGCTTCATGGGATGACCC
  Sirt1                229                     AACACACACACAAAATCCAGCA     TGCAACCTGCTCCAAGGTAT
  Sirt2                248                     TGCAGGAGGCTCAGGATTC        GTCACTCCTTCGAGGGTCAG
  Sirt6                150                     GTCTCACTGTGTCCCTTGTCC      GCGGGTGTGATTGGTAGAGA
  Aox1                 286                     CATAGGCGGCCAGGAACATT       TCCTCGTTCCAGAATGCAGC
  Cox2                 126                     TGACCCCCAAGGCTCAAATA       CCCAGGTCCTCGCTTATGATC
  IL-6                 189                     ATCCAGTTGCCTTCTTGGGACTGA   TAAGCCTCCGACTTGTGAAGTGGT
  Cxcl10               72                      GGCTAGTCCTAATTGCCCTTGG     TTGTCTCAGGACCATGGCTTG
  Actin                190                     CAACGAGCGGTTCCGAT          GCCACAGGTTCCATACCCA
                                                                          
  **Target**           **Product size (bp)**   **Reference**              
                                                                          
  Taqman probes                                                           
  Dnmt3a               58                      Mm00432881 m1              
  Hmox1                69                      Mm00516005_m1              
  Tbp                  93                      Mm00446971_m1              
                                                                          

For SYBER Green, real-time PCR was performed in the Step One Plus Detection System (Applied Biosystems) employing the SYBR Green PCR Master Mix (Applied Biosystems). Each reaction mixture contained 7.5 μL of cDNA, whose concentration was 2 μg, 0.75 uL of each primer (whose concentration was 100 nM), and 7.5 μL of SYBR Green PCR Master Mix (2X), and for TaqMan gene expression assays (Applied Biosystems), for each 20 μL of TaqMan reaction, 9 μL cDNA (18 ng) was mixed with 1 μL 20X probe of TaqMan Gene Expression Assays and 10 μL of 2X TaqMan Universal PCR Master Mix.

Data were analyzed utilizing the comparative Cycle threshold (Ct) method (ΔΔCt), where the actin transcript level was used to normalize differences in sample loading and preparation. Each sample (*n* = 4-5) was analyzed in triplicate, and results represented the *n*-fold difference of transcript levels among different samples.

### Data Analysis

Data are expressed as the mean ± Standard Error of the Mean (SEM) from at least 5--6 samples. Data analysis was conducted using GraphPad Prism version 6 statistical software. Means were compared with the two-tailed, unpaired Student *t-*test. Statistical significance was considered when *p-*values were \<0.05.

Results
=======

EE Mitigates Cognitive Decline in Male SAMP8 Mice
-------------------------------------------------

The Novel Object Recognition Test (NORT) demonstrated significant memory amelioration in SAMP8 EE mice in reference to SAMP8 Controls (Ct) (**Figure [1A](#F1){ref-type="fig"}**). Improvement in cognition was also demonstrated by the results obtained in the Morris Water Maze (MWM) test (**Figure [1B](#F1){ref-type="fig"}**). Moreover, time spent on platform quadrant was longer (**Figure [1C](#F1){ref-type="fig"}**); in contrast, distance swum to platform was significantly lesser in SAMP8 EE than in SAMP8 Ct (**Figure [1D](#F1){ref-type="fig"}**). These results corroborate that previously obtained, but with higher number of animals ([@B27]).

![**Results of the Discrimination Index (DI) of the Novel Object Recognition Test (NORT) (**A)**.** Learning curves during Morris Water Maze (MWM) trials **(B)**. Percentage of time spent in platform zone during 60-sec probe trial of the MWM test **(C)**. Distance to platform **(D)**. Values are mean ± Standard Error of the Mean (SEM); *n* = 10. Statistics: *^∗^p* \< 0.05; *^∗∗^p* \< 0.01; ^∗∗∗^*p* \< 0.001, and ^∗∗∗∗^*p* \< 0.0001, compared with SAMP8 Ct.](fnagi-08-00241-g001){#F1}

Hippocampal Global Changes in DNA Methylation and Hydroxymethylation and Its Machinery after EE
-----------------------------------------------------------------------------------------------

To address the question of whether or not EE could affect DNA methylation or hydroxymethylation, we determined 5-methylcytosine levels and found a significant increase in SAMP8 EE in comparison with SAMP8 Ct (**Figure [2A](#F2){ref-type="fig"}**). In a parallel manner, 5-hmC levels were reduced in SAMP8 EE. When gene expression in DNMTs was studied, only significant decreases in *Dnmt3b* were found (**Figure [2B](#F2){ref-type="fig"}**). Moreover, Ten-eleven Translocation Methylcytosine Dioxygenase 1 (*Tet1*), but not *Tet2*, increased in SAMP8 EE mice (**Figure [2B](#F2){ref-type="fig"}**).

![**Global 5-methylated cytosine and 5-hydroxymethylated cytosine levels **(A)**.** Gene expression for *Dnmt1. Dnmt3a. Dnmt3b. Tet1*, and *Tet2* **(B)**. Gene expression levels were determined by real-time PCR. Presented here are Mean ± Standard Values are means (Standard Error of the Mean \[SEM\]) of the five independent experiments performed in triplicate. ^∗^*p* \< 0.05; ^∗∗^*p* \< 0.01; ^∗∗∗^*p* \< 0.001, and ^∗∗∗∗^*p* \< 0.0001 compared with SAMP8 Ct.](fnagi-08-00241-g002){#F2}

Hippocampal Global Changes in Histone Acetylation Levels and Its Machinery after EE
-----------------------------------------------------------------------------------

The main Histone DeACetylase (HDAC) members of families I and III were studied. HDAC 1 and 2 (representative of the HDAC class I family) exhibited a contrasting profile, with increased gene expression in *Hdac1* and a decrease in *Hdac2. Sirt2* and *Sirt6*, members of HDAC family III, are increased after EE in SAMP8 (**Figure [3C](#F3){ref-type="fig"}**). Protein Acetylated H4 was significantly increased in SAMP8 EE, whereas Acetylated H3 showed increased levels that did not reach significance (**Figures [3A,B](#F3){ref-type="fig"}**), demonstrating that higher levels of *Hdac2* were determining in histone acetylation levels under the EE strategy in SAMP8.

![**Representative Western blot (wb) for acetylated and total H3 and H4 protein levels **(A)** and quantification after Enhanced Environment (EE) intervention **(B)**.** Deacetylase gene expression related with memory for *Hdac1. Hdac2. Sirt1. Sirt2*, and *Sirt6* **(C)**. Values in bar graphs are adjusted to 100% for protein levels of Control SAMP8 (SAMP8 Ct). Gene expression levels were determined by real-time PCR. Mean ± Standard Error of the Mean (SEM) from five independent experiments performed in duplicate are represented. ^∗^*p* \< 0.05 vs. Control SAMP8 (SAMP8 Ct).](fnagi-08-00241-g003){#F3}

Molecular Changes in Nrf2 and NF-κB Pathways Induced by EE
----------------------------------------------------------

To address the question of whether EE increase in antioxidant enzymes is achieved by upregulating Nrf2, we studied protein levels and demonstrated that this transcription factor is translocated into the nucleus in the hippocampus of SAMP8 EE (**Figures [4A,B](#F4){ref-type="fig"}**). In parallel fashion, expression of *Nrf2* target genes was significantly increased in these animals. Concretely, *Hmox1. Aox1*, and *Cox2*, genes coding for oxidative machinery proteins, were upregulated in SAMP8 EE compared with SAMP8 Ct (**Figure [4C](#F4){ref-type="fig"}**).

![**Representative wb for Nuclear regulatory factor 2 (Nrf2) in cytoplasm and nucleus protein levels **(A)** and ration quantification **(B)**.** Nrf2 target-gene expression *Hmox1. Aox1*, and *Cox2* **(C)**. Values in bar graphs are adjusted to 100% for protein levels of Control SAMP8 (SAMP8 Ct). For gene expression, levels were determined by real-time PCR. Mean ± Standard Error of the Mean (SEM) from five independent experiments performed in duplicate are represented. ^∗^*p* \< 0.05 vs. Control SAMP8 (SAMP8 Ct).](fnagi-08-00241-g004){#F4}

Previous results from our laboratory demonstrated that *IL-6* expression was lowered by EE in SAMP8. NF-κB is a transcription factor related with inflammatory response and a master commander in the expression of proinflammatory genes. We found that EE reduced translocation to the nucleus (**Figures [5A,B](#F5){ref-type="fig"}**) and, most importantly, demonstrated that this reduction in nuclear translocation rendered a significantly decrease in *IL-6* and *Cxcl10* gene expression, although no changes were observed in *Tnf-α* (**Figure [5C](#F5){ref-type="fig"}**).

![**Representative wb for Nuclear Factor kappa Beta (NF-κB) in cytoplasm and nucleus protein levels **(A)** and ration quantification **(B)**.** NF-κB target-gene expression *IL-6. Cxcl10*, and *Tnf-α* **(C)**. Values in bar graphs are adjusted to 100% for protein levels of Control SAMP8 (SAMP8 Ct). For gene expression, levels were determined by real-time PCR. Mean ± Standard Error of the Mean (SEM) from five independent experiments performed in duplicate are represented. ^∗^*p* \< 0.05 vs. Control SAMP8 (SAMP8 Ct).](fnagi-08-00241-g005){#F5}

Discussion
==========

In the present study, we showed that EE affected epigenetic markers and produced changes in the transcriptional control of oxidative and inflammaging markers in SAMP8. We hypothesize that changing the environment protectively would modulates a large constellation or at least a large subset of cellular phenotypes of aging. SAMP8 comprises a well-enough, but still not fully characterized, model for studying brain aging and neurodegeneration ([@B68]; [@B57]). Experimental studies on SAMP8 postulated it as a non-transgenic murine model for late-onset AD ([@B58]; [@B52]; [@B57]; [@B12]), in addition to being a spontaneous senescence-accelerated mouse strain. These mice exhibited cognitive and emotional disturbances from young ages, probably due to early development of brain pathological hallmarks, such as OS, inflammation, and activation of neuronal death pathways, which mainly affects cerebral cortex and hippocampus ([@B9]; [@B67]; [@B17]; [@B51]). We have revealed the first, to our knowledge, clue regarding epigenetic modulation in inflammation and oxidative processes in SAMP8 ([@B2]) and in a model of familial AD ([@B28]). Therefore, an adequate epigenetic intervention during early life would be able to have influence on the dysfunctional or harmful molecular mechanisms affected in such a way that this would be able to exert a positive influence ([@B15]).

Molecular changes in young-age SAMP8 are based on cerebral and cognitive dysfunction ([@B72]; [@B2]), and these harmful changes were partially reverted in SAMP8 after EE early exposure, including cognitive, psychoemotional, and neurodegenerative hallmarks of AD ([@B27]). In addition to neuroprotection, EE was able to induce some type of epigenetic modulation in this strain, due to changes in CoREST and LSD1, in both hippocampus and cortex. Therefore, to open the focus on and to probe this epigenetic control, we demonstrated here that the DNA transcriptional control of specific genes indicated its being the initial and key step in the molecular stream developed in SAMP8 by EE, which improves cognition and ameliorates harmful factors gated to neurodegeneration, such as neuronal loss and apoptosis prevention, downregulation of kinase activity, and reduction in OS.

DNA methylation influences hippocampal memory formation, and growing evidence suggests that the regulation of epigenetic processes by EE, stress, and/or hormones can participate in memory function. In the present work and in accordance with the decrease in LSD1 transcription described in [@B27], a higher degree of DNA hypermethylation was found in SAMP8 EE hippocampus. Conversely, only DNMT3b was reduced, whereas other DNMT were not modified. Usually, 5-mC decreases transcriptional access to DNA, although the functional effects of this gene silencing depend on the genes that are altered ([@B2]). However, recent data suggest a more complex role for 5-mC, which also includes stimulation of gene expression ([@B69]; [@B71]). Both, increases and decreases of 5-mC have been described during aging ([@B62]). Furthermore, pathological DNMT activity and aberrant 5-mC formation have been linked with neurodegeneration and apoptotic neuronal death ([@B13]; [@B33]). In these latter studies, neuroprotection was provided by DNMT inhibitors.

5-hmC is another epigenetic marker, catalyzed by the TET family, that appears to be particularly susceptible to developmental and aging-associated modifications ([@B25]; [@B36]). According with other studies, diminution in 5-hmC, which paralleled a decrease in the *Tet1* expression level, was found after EE in SAMP8. For instance, [@B35] found that aged mice exposed to EE improved learning and memory, reducing 5-hmC-abundant hippocampus. However, in this work, no changes in *Tet1* expression were found, and differences can be explained by different timing in EE and also because of differences in strain and age. In sum, aging-associated 5-hmC alterations appear to be likely participants in the neuroplasticity of the aging brain.

In addition to DNA methylation changes, histone alterations are one of epigenetic mechanisms that are essential for hippocampal synaptic plasticity and cognitive function diseases ([@B74]). In total, histone acetylation increases gene transcriptional activity by relaxing chromatin ([@B19]). The role of histone acetylation in memory has been intensively explored in recent years. Increasing histone H3 and H4 acetylation by means of HDAC inhibitors in the dorsal hippocampus enhances several types of hippocampal-dependent memories ([@B66]; [@B31]), and also rescued hippocampal memory deficits in mouse models of AD ([@B63]; [@B39]) and on aged rats ([@B55]). Different classes of HDAC can be distinctly involved in memory formation or in neurodegeneration. For instance, *Hdac1* expression is upregulated in a mouse model for Huntington's disease ([@B61]). However, mice lacking or overexpressing neuronal HDAC1 from early developmental stages are viable and display normal memory function ([@B30]). Here, a significant increase in H3 and H4 acetylation levels were found after EE in SAMP8. Although changes in *Hdac1. Sirt2*, and *Sirt6* revealed an increase in gene expression, *Hdac2* gene expression was significantly reduced, pointing to a major role of this deacetylase in the beneficial action of EE on the SAMP8 strain ([@B27]). Interestingly, HDAC2 is one of the major regulators involved in the regulation of long-term memory. Specifically, mice overexpressing HDAC2 exhibited memory impairment, while HDAC2-knockout mice demonstrated enhanced synaptic plasticity ([@B30]).

On the other hand, and in the same line of all previously mentioned herein, we found an increase in two transcriptional regulatory pathways; Nrf2 and NF-κB, despite the hypermethylation induced by EE. Thus, we can deduce that EE-induced hypermethylation of low-density CpG islands were the promoter for Nrf2, the Antioxidant Response Element (ARE), and for NF-κB.

It is well known that OS possesses a pre-eminent role in the pathogenesis of AD, and in addition, decreased expression of Nrf2 has been reported in AD ([@B10]). In response to OS, Nrf2 is translocated from the cytoplasm to the nucleus and subsequently binds with ARE, in turn promoting the expression of a variety of OS-related genes ([@B1]).

We found that in SAMP8 EE, there was significant Nrf2 nuclear translocation, and this in turn could induce the transcription of Heme oxygenase (decycling) 1 (*Hmox1*), Aldehyde oxidase 1 (*Aox1*), and Cyclooxygenase 2 (*Cox2*) genes. *Hmox1* can exert cytoprotective effects against OS, whereas *Aox1* and *Cox2* mediated Reactive Oxygen Species (ROS). These latter factors can act as hormetic regulators in an oxidative environment, favoring the cellular defenses confronting OS ([@B8]; [@B44]). Other target genes, such as Aldehyde dehydrogenase 2 (*Aldh2*), were not affected (data not shown). It is also relevant that memory improvement in Nrf2-level modulation has been reported in aged APP/PS1 mice ([@B38]) and in memory-impaired rats ([@B20]).

On the other hand, the high levels of inflammatory mediators can increase a physiological response to certain pathological conditions in the nervous system, as AD or stroke, and It has been suggested that modulation of the signaling pathways of these mediators could be a potential therapeutic approach ([@B7]; [@B11]). Here, we have studied NF-κB, that is a transcription factor in positive feedback with and exercising a regulatory role in relationship to classic pro-inflammatory signals that also impacts cell survival and apoptosis, allowing cells to adapt and respond to environmental changes ([@B56]). In a previous work, we described that EE induced a significant decrease of *IL-6* gene expression in the SAMP8 EE group compared with SAMP8 Ct ([@B27]). IL-6 is a pleiotropic inflammatory cytokine secreted by activated glia in the Central Nervous System (CNS) and is involved in mood disorders such as depression, also in aging process and the pathogenesis of neurodegenerative diseases such as AD ([@B60]; [@B59]). Our results demonstrate significant lowest genetic expression for *IL-6*, and also for *Cxcl10*, but not for Tumor necrosis factor alpha (*Tnf-α*) in the SAMP8 EE group. C-X-C motif chemokine 10 (*Cxcl10*) CXCL10 is secreted by several cell types in response to InterFeroN gamma (IFN-γ) and was found increased in AD mouse models ([@B73]). These results coincide with a decrease in the nuclear translocation of proinflammatory transcription factor NF-κB in SAMP8 mouse EE.

Taken together, our results showed that crucial epigenetic modifications were demonstrated in the SAMP8 EE paradigm, reducing proinflammatory and OS pathways. Therefore, epigenetics orchestrated the homeostasis among DNA methylation, histone acetylation, and transcription factors, acting as a crosstalk mechanism and leading cognitive improvement and neuroprotection after EE in SAMP8 (**Figure [6](#F6){ref-type="fig"}**).

![**Representative rendering of epigenetic and molecular mechanisms modified in Senescence-Accelerated Prone Mice P8 (SAMP8) after EE**.](fnagi-08-00241-g006){#F6}
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